Johnkim_sio2 · Newsroom
SiO2 Scales Manufacturing of Hybrid Vial Capacity for 400 Million Doses of COVID-19 Vaccine Achieved Ahead of Schedule
SiO2 Materials Science, an advanced materials science company, announced they have successfully scaled their manufacturing capacity ahead of schedule to 400 million doses and are on track to hit 1.2 billion capacity before the end of 2020.July 15, 2020